BioNote Inc
KRX:377740
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
BioNote Inc
EPS (Diluted)
BioNote Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BioNote Inc
KRX:377740
|
EPS (Diluted)
₩542
|
CAGR 3-Years
-58%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
EPS (Diluted)
₩4.7k
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
17%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
EPS (Diluted)
-₩1.9k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
EPS (Diluted)
₩2.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
55%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
EPS (Diluted)
-₩734
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
EPS (Diluted)
-₩705
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNote Inc
Glance View
BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
See Also
What is BioNote Inc's EPS (Diluted)?
EPS (Diluted)
542
KRW
Based on the financial report for Dec 31, 2024, BioNote Inc's EPS (Diluted) amounts to 542 KRW.
What is BioNote Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
22%
The average annual EPS (Diluted) growth rates for BioNote Inc have been -58% over the past three years , 22% over the past five years .
